Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases

This publication has 35 references indexed in Scilit:

• Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002
  International Journal of Antimicrobial Agents, 2004
• Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
  Antimicrobial Agents and Chemotherapy, 2004
• Discovery of CTX-M-Like Extended-Spectrum β-Lactamases in Escherichia coli Isolates from Five U.S. States
  Antimicrobial Agents and Chemotherapy, 2003
• Characterization of cefotaxime-resistant Escherichia coli isolates from a nosocomial outbreak at three geriatric hospitals
  Journal of Infection and Chemotherapy, 2002
• Control of an Outbreak of Infection Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliin a Liver Transplantation Unit
  Clinical Infectious Diseases, 2001
• CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes
  International Journal of Antimicrobial Agents, 2000
• Multiple Antibiotic–Resistant Klebsiella and Escherichia coli in Nursing Homes
  JAMA, 1999
• Diversification of Escherichia coli Expressing an SHV-Type Extended-Spectrum β-Lactamase (ESBL) during a Hospital Outbreak: Emergence of an ESBL-Hyperproducing Strain Resistant to Expanded-Spectrum Cephalosporins
  Antimicrobial Agents and Chemotherapy, 1999
• A functional classification scheme for beta-lactamases and its correlation with molecular structure
  Antimicrobial Agents and Chemotherapy, 1995
• Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
  Infection, 1983